반응형

ldt 3

[Emergo, UL] District Court Ruling on FDA Final Rule Regarding Laboratory Developed Tests (LDTs)

Court decision on LDTsOn March 31, 2025, the US District Court (Eastern District of Texas, Sherman Division) ruled that the FDA’s Final Rule on Laboratory Developed Tests (LDTs) published in 2024, which phases out enforcement discretion and phases in standard medical device requirements, be vacated and set aside. This court determined that Congress has vested authority of test services to the Ce..

뉴스 보고서 2025.04.10

[Emergo, UL] US FDA Warning Letters: Considerations for LDTs including Timelines

Importance of reviewing warning lettersBy reviewing relevant U.S. Food and Drug Administration (FDA) warning letters, manufacturers can better understand areas of frequent concern related to quality management systems (QMS) and regulatory affairs. This can allow companies to focus on areas of highest risk as they continually assess and improve their internal procedures and processes. It also hel..

뉴스 보고서 2025.04.03

[Emergo, UL] U.S. FDA Stage 1 Requirements for Laboratory Developed Tests

In its August 22 webinar, the U.S. Food and Drug Administration (FDA) discussed the Stage 1 requirements imposed on laboratory-developed test (LDT) manufacturers.U.S. FDA Final Rule on LDTsLDTs are in vitro diagnostic devices (IVDs) that are designed, manufactured and used within a single clinical laboratory and were placed under enforcement discretion in 1976 with the medical device amendments ..

뉴스 보고서 2024.09.09
반응형